Where can I find INDP's financial statements?

Indaptus Therapeutics, Inc. (INDP)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for INDP?

Indaptus Therapeutics, Inc. (INDP) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does INDP update its statements?

Indaptus Therapeutics, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

INDP

Indaptus Therapeutics, Inc.

NASDAQ·Biotechnology · Healthcare

$1.16$0.02+1.75%

After hours·$1.16+0.00%

Market cap$131.36M·Market closed·Aug 27 8:00 PM UTC

USD · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Gross profit	$0.00	$0.00	$0.00	$0.00	$0.00
Research & development	$2.52M−5.0%	$6.32M+150.7%	$7.62M+20.5%	$7.25M−4.9%	$9.34M+28.8%
General & administrative	$5.21M+451.3%	$8.59M+64.9%	$8.76M+2.0%	$8.11M−7.3%	$10.49M+29.3%
SG&A (combined)	$5.21M+451.3%	$8.59M+64.9%	$8.76M+2.0%	$8.11M−7.3%	$10.49M+29.3%
Other operating expenses	—	—	—	$0.00	—
Total operating expenses	$7.73M+114.7%	$14.91M+92.9%	$16.38M+9.8%	$15.37M−6.2%	$19.83M+29.1%
Operating income	−$7.73M−114.7%	−$14.91M−92.9%	−$16.38M−9.8%	−$15.37M+6.2%	−$19.83M−29.1%
Interest income	$17.72K	$588.11K+3,218.5%	—	—	—
Other income / (expense), net	$17.72K+17.3%	$588.11K+3,218.5%	$955.00K+62.4%	$343.72K−64.0%	−$1.02M−395.4%
Income before tax	−$7.71M−115.2%	−$14.32M−85.7%	−$15.42M−7.7%	−$15.02M+2.6%	−$20.85M−38.8%
Net income	−$7.71M−115.2%	−$14.32M−85.7%	−$15.42M−7.7%	−$15.02M+2.6%	−$20.85M−38.8%

EPS (basic)	−$52.78+74.4%	−$48.54+8.0%	−$51.41−5.9%	−$44.96+12.5%	−$21.58+52.0%
EPS (diluted)	−$52.78+74.4%	−$48.54+8.0%	−$51.41−5.9%	−$44.96+12.5%	−$21.58+52.0%
Weighted avg shares (basic)	146,092	295,075	300,037	334,132	966,124
Weighted avg shares (diluted)	146,092	295,075	300,037	334,132	966,124

Depreciation & amortization	$1.40K+64.7%	$1.78K+26.9%	$1.28K−27.9%	$735.00−42.8%	—
EBITDA	−$7.71M−114.3%	−$14.32M−85.7%	−$15.42M−7.7%	−$15.02M+2.6%	−$20.85M−38.8%

Frequently Asked Questions About INDP

Where can I find INDP's financial statements?: Indaptus Therapeutics, Inc. (INDP)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for INDP?: Indaptus Therapeutics, Inc. (INDP) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does INDP update its statements?: Indaptus Therapeutics, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.